David Gayton, MD
Family Medicine · Bismarck, NDNPI 1356433718
Payments from drug & device makers
Across 19 payments — averaging $19.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$84
- Exact Sciences$83
- E.r. Squibb & Sons, L.L.C.$45
- AbbVie$40
- Lilly USA, LLC$28
- Johnson & Johnson$20
- plus $76 from 5 others
What the payments were for
- Food & beverage$375100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 2 | $84 |
| Exact Sciences | 5 | $83 |
| E.r. Squibb & Sons, L.L.C. | 2 | $45 |
| AbbVie | 2 | $40 |
| Lilly USA, LLC | 2 | $28 |
| Johnson & Johnson | 1 | $20 |
| Inari Medical, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| GSK | 1 | $16 |
| Actelion Pharmaceuticals US, Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$375 in reported general payments places this provider in the 65th percentile of 337 family medicine providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PaxlovidNirmatrelvir/Ritonavir | 20 | $2,796 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 21 | $593 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 49 | $443 |
| Doxycycline Hyclate | 62 | $422 |
| Cephalexin | 35 | $340 |
| Amoxicillin | 65 | $261 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 28 | $222 |
| MoxifloxacinMoxifloxacin Hcl | 14 | $210 |
| Triamcinolone Acetonide | 24 | $195 |
| CefuroximeCefuroxime Axetil | 19 | $187 |
| Prednisone | 84 | $129 |
| Azithromycin | 31 | $96 |
| Fluconazole | 14 | $91 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $79 |
| Ondansetron OdtOndansetron | 12 | $70 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Bismarck
- Jacqueline QuisnoBismarck$19K
- Jeffrey SmithBismarck$15K
- Stuart SmithBismarck$8K
- David PengillyBismarck$8K
- Biron BakerBismarck$8K
- Michelle TincherBismarck$7K
- Kevin LongieBismarck$6K
- Kelly LongieBismarck$5K
- Sherry SteinBismarck$5K
- David FieldBismarck$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.